BioCentury
ARTICLE | Company News

EntreMed, Miikana deal

January 2, 2006 8:00 AM UTC

Cancer and inflammation company ENMD will acquire Miikana for 10 million shares, which values Miikana at $21.2 million using ENMD's close of $2.13 on Dec. 21, the day before the deal was announced. Miikana shareholders are eligible for up to $18 million in milestones, payable in cash or stock at ENMD's option. The deal is expected to close this month. ...